Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6683
|
pubmed:dateCreated |
1998-6-15
|
pubmed:databankReference | |
pubmed:abstractText |
The physiological effects of progestins are mediated by the progesterone receptor, a member of the steroid/nuclear receptor superfamily. As progesterone is required for maintenance of pregnancy, its receptor has been a target for pharmaceuticals. Here we report the 1.8 A crystal structure of a progesterone-bound ligand-binding domain of the human progesterone receptor. The nature of this structure explains the receptor's selective affinity for progestins and establishes a common mode of recognition of 3-oxy steroids by the cognate receptors. Although the overall fold of the progesterone receptor is similar to that found in related receptors, the progesterone receptor has a quite different mode of dimerization. A hormone-induced stabilization of the carboxy-terminal secondary structure of the ligand-binding domain of the progesterone receptor accounts for the stereochemistry of this distinctive dimer, explains the receptor's characteristic pattern of ligand-dependent protease resistance and its loss of repression, and indicates how the anti-progestin RU486 might work in birth control. The structure also indicates that the analogous 3-keto-steroid receptors may have a similar mechanism of action.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Hormone Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Ligands,
http://linkedlifedata.com/resource/pubmed/chemical/Mifepristone,
http://linkedlifedata.com/resource/pubmed/chemical/Progesterone,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0028-0836
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
28
|
pubmed:volume |
393
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
392-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9620806-Amino Acid Sequence,
pubmed-meshheading:9620806-Binding Sites,
pubmed-meshheading:9620806-Crystallography, X-Ray,
pubmed-meshheading:9620806-Escherichia coli,
pubmed-meshheading:9620806-Hormone Antagonists,
pubmed-meshheading:9620806-Humans,
pubmed-meshheading:9620806-Ligands,
pubmed-meshheading:9620806-Mifepristone,
pubmed-meshheading:9620806-Models, Molecular,
pubmed-meshheading:9620806-Molecular Sequence Data,
pubmed-meshheading:9620806-Progesterone,
pubmed-meshheading:9620806-Protein Conformation,
pubmed-meshheading:9620806-Receptors, Progesterone,
pubmed-meshheading:9620806-Recombinant Fusion Proteins
|
pubmed:year |
1998
|
pubmed:articleTitle |
Atomic structure of progesterone complexed with its receptor.
|
pubmed:affiliation |
Department of Molecular Biophysics and Biochemistry, and the Howard Hughes Medical Institute, Yale University, New Haven, Connecticut 06510, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|